A client is admitted with tachycardia, hypertension, restlessness, agitation, and admits substance use. Which substance would be most likely to cause these symptoms?
A depressant
An opioid
A stimulant
An inhalant
The Correct Answer is C
A. A depressant Depressants typically slow down the central nervous system, leading to
symptoms like sedation, slowed heart rate, and reduced blood pressure. The symptoms described in the question, such as tachycardia, hypertension, restlessness, and agitation, are not
characteristic of depressant use.
B. An opioid Opioids primarily lead to central nervous system depression, resulting in symptoms like respiratory depression, sedation, and decreased heart rate. The symptoms described in the question, such as tachycardia and restlessness, are not typical of opioid use.
C. A stimulant Stimulants, such as amphetamines or cocaine, lead to increased activity in the central nervous system, resulting in symptoms like tachycardia, hypertension, restlessness, and agitation. These symptoms align with the presentation described in the question.
D. An inhalant Inhalants can lead to a variety of effects, including dizziness, confusion, and sometimes increased heart rate. However, they are not typically associated with the specific symptoms of tachycardia, hypertension, restlessness, and agitation described in the question.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Increasing aggression may be an indication for a PRN medication, but benztropine specifically targets extrapyramidal symptoms (EPS).
B. Elevated blood pressure is not a direct indication for benztropine; it is used to address EPS.
C. Complaints of dizziness may not be directly related to EPS, which is the target of benztropine.
D. Benztropine is an anticholinergic medication used to manage extrapyramidal symptoms (EPS) associated with antipsychotic medications like haloperidol.
Correct Answer is D
Explanation
A. This option is too vague and doesn't provide specific guidance about the detoxification process for alprazolam.
B. Frequency of usage is one factor, but it's not the only consideration in the detoxification process.
C. A planned reduction is necessary to safely taper off alprazolam and minimize withdrawal symptoms.
D. This option provides the best guidance, emphasizing the importance of a gradual and controlled tapering process for alprazolam.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today